ZYUS Life Sciences Corporation
ZYUS.V
TSX
Weiss Ratings | ZYUS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | E | |||
Rating Factors | ZYUS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Fair | |||
Efficiency Index | Very Weak | |||
Solvency Index | Fair | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | ZYUS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -- | |||
Price History | ZYUS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 2.56% | |||
30-Day Total Return | -4.76% | |||
60-Day Total Return | -11.11% | |||
90-Day Total Return | 1.27% | |||
Year to Date Total Return | -14.89% | |||
1-Year Total Return | -25.93% | |||
2-Year Total Return | -- | |||
3-Year Total Return | -- | |||
5-Year Total Return | -- | |||
52-Week High % Change | -38.66% | |||
52-Week Low % Change | 4.29% | |||
Price | ZYUS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $1.19 | |||
52-Week Low Price | $0.70 | |||
52-Week Low Price (Date) | Nov 18, 2024 | |||
52-Week High Price (Date) | May 08, 2024 | |||
Valuation | ZYUS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 37.74M | |||
Enterprise Value | 43.02M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.39 | |||
Earnings Per Share Growth | -3.93% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 158.70 | |||
Price/Book (Q) | 4.93 | |||
Enterprise Value/Revenue (TTM) | 128.98 | |||
Price | $0.80 | |||
Enterprise Value/EBITDA (TTM) | -3.57 | |||
Enterprise Value/EBIT | -3.09 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | ZYUS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 72.18M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | ZYUS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 888 651 9987 | |||
Address | Unit 204 Saskatoon, SK S7N 4L8 | |||
Website | www.zyus.com | |||
Country | Canada | |||
Year Founded | 2018 | |||
Profitability | ZYUS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -4,180.13% | |||
Profit Margin | -8,083.74% | |||
Management Effectiveness | ZYUS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -22.19% | |||
Return on Equity | -- | |||
Income Statement | ZYUS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 332.30K | |||
Total Revenue (TTM) | 332.30K | |||
Revenue Per Share | $0.01 | |||
Gross Profit (TTM) | -1.42M | |||
EBITDA (TTM) | -12.00M | |||
EBIT (TTM) | -13.89M | |||
Net Income (TTM) | -26.86M | |||
Net Income Avl. to Common (TTM) | -26.86M | |||
Total Revenue Growth (Q YOY) | 22.22% | |||
Earnings Growth (Q YOY) | 8.11% | |||
EPS Diluted (TTM) | -0.39 | |||
EPS Diluted Growth (Q YOY) | 11.16% | |||
Balance Sheet | ZYUS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 256.10K | |||
Cash Per Share (Q) | $0.00 | |||
Total Current Assets (Q) | 2.58M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 11.02M | |||
Current Ratio (Q) | 0.243 | |||
Book Value Per Share (Q) | $0.15 | |||
Total Assets (Q) | 25.15M | |||
Total Current Liabilities (Q) | 10.58M | |||
Total Debt (Q) | 5.88M | |||
Total Liabilities (Q) | 14.13M | |||
Total Common Equity (Q) | 11.02M | |||
Cash Flow | ZYUS.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -174.40K | |||
Cash from Financing (TTM) | 476.00K | |||
Net Change in Cash (TTM) | -5.14M | |||
Levered Free Cash Flow (TTM) | -2.51M | |||
Cash from Operations (TTM) | -5.45M | |||